Publications by authors named "Stephan Jacob"

Claim this Profile
I
Improved cardiovascular outcomes with glucagon-like peptide-1 receptor agonists - what is the role of weight reduction?
Stephan Jacob, Robert H Eckel, Andrew J Krentz

Cardiovasc Endocrinol Metab· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global cardiometabolic alliance: A clinical and research initiative addressing the 21st century pandemic of insulin resistance-associated disease.
Robert H Eckel, Andrew J Krentz, Stephan Jacob, Peter Libby

Diabetes Obes Metab· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity.
Sean Wharton, Ildiko Lingvay, Pawel Bogdanski, Ruben Duque do Vale, Stephan Jacob

N Engl J Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Rising to the challenge of cardio-renal-metabolic disease in the 21st century: Translating evidence into best clinical practice to prevent and manage atherosclerosis" [Atherosclerosis, Vol 396, (September 2024), 118528].

Atherosclerosis· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rising to the challenge of cardio-renal-metabolic disease in the 21st century: Translating evidence into best clinical practice to prevent and manage atherosclerosis.

Atherosclerosis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes.
Oliver Schnell, Katharine Barnard-Kelly, Tadej Battelino, Antonio Ceriello, Helena Elding Larsson, Stephan Jacob

Cardiovasc Diabetol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from SemaglUtide Real-world Evidence (SURE) Germany.
Markus Menzen, Tina Landsvig Berentzen, Andrei-Mircea Catarig, Sebastian Pieperhoff, Jörg Simon, Stephan Jacob

Exp Clin Endocrinol Diabetes· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prioritizing obesity treatment: expanding the role of cardiologists to improve cardiovascular health and outcomes.
Donna H Ryan, John E Deanfield, Stephan Jacob

Cardiovasc Endocrinol Metab· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of once-weekly semaglutide versus thrice-daily insulin aspart, both as add-on to metformin and optimized insulin glargine treatment in participants with type 2 diabetes (SUSTAIN 11): A randomized, open-label, multinational, phase 3b trial.
Monika Kellerer, Margit Staum Kaltoft, Jack Lawson, Lasse Lykke Nielsen, Krzysztof Strojek, Stephan Jacob

Diabetes Obes Metab· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of efpeglenatide in key patient subgroups from the BALANCE randomized trial, stratified by pre-diabetes status, BMI, and age at baseline.
Richard E Pratley, Stephan Jacob, Seungjae Baek, Michael E Trautmann, Marcus Hompesch

BMJ Open Diabetes Res Care· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of Type 2 Diabetes Management from a Glucocentric Approach to Cardio-Renal Risk Reduction: The New Paradigm of Care.
Stephan Jacob, Andrew J Krentz, John Deanfield, Lars Rydén

Drugs· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular outcome trials in obesity: A review.
John P H Wilding, Stephan Jacob

Obes Rev· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The future of cardiovascular and metabolic medical practice: evidence-based winds of change.
Andrew J Krentz, Stephan Jacob

Cardiovasc Endocrinol Metab· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exercise prescription in patients with type 2 diabetes and coronary heart disease: could less be more?
Stephan Jacob, Andrew J Krentz

Cardiovasc Endocrinol Metab· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body weight management and safety with efpeglenatide in adults without diabetes: A phase II randomized study.
Richard E Pratley, Jahoon Kang, Michael E Trautmann, Marcus Hompesch, OakPil Han, Stephan Jacob

Diabetes Obes Metab· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and safety of combined insulin and glucagon-like peptide-1 therapy: Evidence from the LEADER trial.
Cees J Tack, Stephan Jacob, Cyrus Desouza, Stephen C Bain, John B Buse

Diabetes Obes Metab· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Prevention of CV complications in DM2 - which targets should be used?].
Stephan Jacob

MMW Fortschr Med· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triple therapy with low-dose dapagliflozin plus saxagliptin versus dual therapy with each monocomponent, all added to metformin, in uncontrolled type 2 diabetes.
Julio Rosenstock, Shira Perl, Eva Johnsson, Ricardo García-Sánchez, Stephan Jacob

Diabetes Obes Metab· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiometabolic medicine: time to recognize a new clinical specialty?
Andrew J Krentz, Stephan Jacob

Cardiovasc Endocrinol Metab· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add-on to metformin in patients with type 2 diabetes.
Dirk Müller-Wieland, Monika Kellerer, Katarzyna Cypryk, Dasa Skripova, Katja Rohwedder, Stephan Jacob

Diabetes Obes Metab· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
'
'Knowing what Matters in diabetes: Healthier below 7': results of the campaign's first 10 years (part 2), participants without known diabetes history.
Stephan Jacob, Andrea Klimke-Huebner, Franz W Dippel, Werner Hopfenmueller

Cardiovasc Endocrinol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Usability Evaluation of a Blood Glucose Monitoring System With a Spill-Resistant Vial, Easier Strip Handling, and Connectivity to a Mobile App: Improvement of Patient Convenience and Satisfaction.
Craig Harvey, Richard Koubek, Vanessa Bégat, Stephan Jacob

J Diabetes Sci Technol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LEADER-4: blood pressure control in patients with type 2 diabetes and high cardiovascular risk: baseline data from the LEADER randomized trial.
John R Petrie, Steven P Marso, Stephen C Bain, Edward Franek, Stephan Jacob

J Hypertens· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Insulin therapy: as late as possible].
Stephan Jacob

Dtsch Med Wochenschr· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
'
'Knowing what matters in diabetes: healthier below 7': results of the campaign's first 10 years (part 1): participants with known type 2 diabetes.
Stephan Jacob, Andrea Klimke-Hübner, Franz-Werner Dippel, Werner Hopfenmüller

Cardiovasc Endocrinol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis